drugset / Trial / NCT01201551

Effect of Alphagan and Xalatan Eye Drops on Corneal Temperature

NCT01201551

Non-randomizedParallel-groupSingle-blindTreatment

Summary

It is already known that the local treatment with Alphagan eye drops (a drug commonly used by glaucoma patients) reduces ocular blood flow. In-vitro studies suggest that the vasoconstrictive effect of Alphagan is more pronounced when this drug is combined with a prostaglandin analogue (eg. Xalatan eye drops). The investigators also question whether this effect is more pronounced in subjects suffering from a primary vascular dysregulation (PVD). To test for the effect of these drugs on PVD and non-PVD subjects the investigators will take measurements of corneal temperature as surrogate for ocular blood flow.

Timeline

Start
2011-06
Primary completion
2013-11
Completion
2013-11

Drugs

EvaluationDrugModalityDoseRoute
Comparator Brimonidine Small molecule Other
Comparator Latanoprost Small molecule Other

Indications